200
Participants
Start Date
October 9, 2024
Primary Completion Date
December 30, 2028
Study Completion Date
December 30, 2029
Blood Specimen Collection
Approximately 20 mL of peripheral blood (10 mL per tube, x 3 Streck tubes) will be drawn at each time point
Tumor Tissue Collection
Formalin-fixed paraffin embedded tumor tissue samples (tissue blocks of 12 x 10 millimeter (mm) unstained slides) derived from biopsy or surgical resection will be collected at screening
Medical Record Review
Medical records will be reviewed to collect standard of care p16 staining by immunohistochemistry and/or high-risk human papillomavirus (HPV) DNA or RNA testing that is performed as part of standard of care
RECRUITING
University of California, San Francisco, San Francisco
Haystack Oncology, Inc.
UNKNOWN
University of California, San Francisco
OTHER